Camilla Ardinghi
C.V.

  1. Silini A, Ghilardi C, Ardinghi C, Bernasconi S, Oliva P, Carraro F, Naldini A, Bani MR, Giavazzi R. Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clin Exp Metastasis. 27(1):43-53,2010
  2. Naldini A., Filippi I., Ardinghi C., Silini A., Giavazzi R., Carraro F. Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells. Eur J Cancer. 45(3):454-60, 2009
  3. Materazzi S., Pellerito S., Di Serio C., Paglierani M., Naldini A., Ardinghi C., Carraro F., Geppetti P., Cirino G., Santucci M., Tarantini F., Massi D. Analysis of protease-activated receptor-1 and -2 in human scar formation. Journal of  Pathology  212(4):440-9, 2007
  4. Naldini A., Ardinghi C., Massi D., Santucci M., Franchi A., Tarantini F., Geppetti P., Cirino G., and Carraro F. A Ribonuclease Protection Assay-Based approach for Analysis of Angiogegenic Gene Expression in Archival Tissues. Diagnostic Molecular Pathology. 16(3):147-52,2007
  5. Franchi A., Massi D., Santucci M., Masini E., Degl’Innocenti Rossi D., Magnelli L., Fanti E., Naldini A., Ardinghi C., Carraro F., and Gallo O. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.  Journal of  Pathology  208(3):439-45, 2006
  6. Massi D., Naldini A., Ardinghi C., Carraro F., Franchi A., Paglierani M., Tarantini F., Ketabchi S., Cirino G., Hollenberg MD., Geppetti P., and Santucci M. Expression of protease-activator receptors 1 and 2 in melanocytic nevi and malignant melanoma. Human Pathology 36: 676-685, 2005